Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.
作者信息
Simmons R L, Rios A
出版信息
Ann Surg. 1972 Aug;176(2):188-94. doi: 10.1097/00000658-197208000-00011.
Abstract
摘要
相似文献
1
Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.使用神经氨酸酶对甲基胆蒽纤维肉瘤进行免疫特异性消退。3. 卡介苗与经神经氨酸酶处理的肿瘤细胞的协同作用。
Ann Surg. 1972 Aug;176(2):188-94. doi: 10.1097/00000658-197208000-00011.
2
3
Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.卡介苗与神经氨酸酶在实验性免疫治疗中的比较及联合作用
Natl Cancer Inst Monogr. 1973 Dec;39:57-68.
4
Immunotherapy of cancer: immunospecific rejection of tumors in recipients of neuraminidase-treated tumor cells plus BCG.癌症免疫疗法：经神经氨酸酶处理的肿瘤细胞加卡介苗受体中肿瘤的免疫特异性排斥反应
Science. 1971 Nov 5;174(4009):591-3. doi: 10.1126/science.174.4009.591.
5
Neuraminidase treated cells and their role in cancer immunotherapy.神经氨酸酶处理过的细胞及其在癌症免疫治疗中的作用。
Birth Defects Orig Artic Ser. 1973 Mar;9(2):223-8.
6
Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.使用神经氨酸酶对甲基胆蒽纤维肉瘤进行免疫特异性消退
Surgery. 1971 Jul;70(1):38-46.
7
Regression of established methylcholanthrene tumors by intratumor injections of Vbrio cholerae neuraminidase.通过瘤内注射霍乱弧菌神经氨酸酶使已形成的甲基胆蒽肿瘤消退。
J Surg Oncol. 1972;4(4):298-305. doi: 10.1002/jso.2930040403.
8
Active specific immunotherapy of minimal residual tumor: excision plus neuraminidase-treated tumor cells.
Int J Cancer. 1974 Jan 15;13(1):71-81. doi: 10.1002/ijc.2910130109.
9
Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.神经氨酸酶与伴刀豆球蛋白A在癌症实验性免疫治疗中的应用
Johns Hopkins Med J Suppl. 1974;3:75-84.
10
Effect of neuraminidase on growth of a 3-methylcholanthrene-induced fibrosarcoma in normal and immunosuppressed syngeneic mice.神经氨酸酶对正常和免疫抑制同基因小鼠中3-甲基胆蒽诱导的纤维肉瘤生长的影响。
J Natl Cancer Inst. 1971 Nov;47(5):1087-94.
引用本文的文献
1
Antitumor immune response following injection of neuraminidase-treated sarcoma cells.注射神经氨酸酶处理的肉瘤细胞后的抗肿瘤免疫反应。
Ann Surg. 1975 Mar;181(3):359-62. doi: 10.1097/00000658-197503000-00018.
2
Immunology of bronchial carcinoma.支气管癌的免疫学
Thorax. 1976 Oct;31(5):493-506. doi: 10.1136/thx.31.5.493.
本文引用的文献
1
CYTOTOXIC TEST FOR DEMONSTRATION OF MOUSE ANTIBODY.用于证明小鼠抗体的细胞毒性试验。
Methods Med Res. 1964;10:39-47.
2
ELECTROPHORETIC STUDIES ON SOME TYPES OF MAMMALIAN TISSUE CELL.某些类型哺乳动物组织细胞的电泳研究
Cancer Res. 1964 Dec;24:2038-43.
3
The effect of neuraminidase on the phagocytic process in human monocytes.神经氨酸酶对人单核细胞吞噬过程的影响。
Lab Invest. 1966 Aug;15(8):1304-9.
4
Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase.在神经氨酸酶中孵育后，甲基胆蒽诱导的肉瘤细胞的肿瘤特异性免疫原性。
Br J Cancer. 1969 Mar;23(1):141-9. doi: 10.1038/bjc.1969.21.
5
The effect of neuraminidase on the fate of transfused lymphocytes.神经氨酸酶对输注淋巴细胞命运的影响。
J Exp Med. 1969 Mar 1;129(3):551-67. doi: 10.1084/jem.129.3.551.
6
The role of sialic acid in antigenic expression: further studies of the Landschütz ascites tumour.唾液酸在抗原表达中的作用：对兰施胡茨腹水瘤的进一步研究。
Br J Cancer. 1968 Dec;22(4):843-53. doi: 10.1038/bjc.1968.99.
7
Immunogenicity of L 1210 murine leukaemia cells after treatment with neuraminidase.神经氨酸酶处理后L1210小鼠白血病细胞的免疫原性
Nature. 1968 Jun 29;218(5148):1254-5. doi: 10.1038/2181254a0.
8
Antigenic specificities on murine sarcoma cells. Reciprocal relationship between normal transplantation antigens (H-2) and tumor-specific immunogenicity.鼠肉瘤细胞上的抗原特异性。正常移植抗原（H-2）与肿瘤特异性免疫原性之间的相互关系。
J Exp Med. 1971 Jun 1;133(6):1171-87. doi: 10.1084/jem.133.6.1171.
9
Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy.人类肉瘤和黑色素瘤中的免疫因素：免疫治疗的合理依据。
Ann Surg. 1970 Oct;172(4):740-9. doi: 10.1097/00000658-197010000-00018.
10
Further studies on the effect of neuraminidase on tumor cell transplantability.关于神经氨酸酶对肿瘤细胞移植性影响的进一步研究。
Tissue Antigens. 1971;1(4):153-61. doi: 10.1111/j.1399-0039.1971.tb00092.x.
Zotero 插件